References: Nausea and vomiting in palliative care
Al-Saffar A, Lennernas H, Hellstrom PM. Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited. Neurogastroenterol Motil 2019;31(11):e13617. https://www.ncbi.nlm.nih.gov/pubmed/31050085
Hardy J, Davis MP. The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer. Curr Treat Options Oncol 2021;22(2):17. https://www.ncbi.nlm.nih.gov/pubmed/33443705
Hardy J, Skerman H, Glare P, Philip J, Hudson P, Mitchell G, et al. A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment. BMC Cancer 2018;18(1):510. https://www.ncbi.nlm.nih.gov/pubmed/29720113
Hardy JR, Skerman H, Philip J, Good P, Currow DC, Mitchell G, et al. Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. BMJ Open 2019;9(9):e029942. https://www.ncbi.nlm.nih.gov/pubmed/31515428
Heckroth M, Luckett RT, Moser C, Parajuli D, Abell TL. Nausea and Vomiting in 2021: A Comprehensive Update. J Clin Gastroenterol 2021;55(4):279-99. https://pubmed.ncbi.nlm.nih.gov/33471485/
